DAIC

JUNE 11, 2024

Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.

Innovation 104

Innovation AFIB Technology Electrophysiology 104

DAIC

FEBRUARY 2, 2024

milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. million people in the United States by 2050 and 17.9

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. 1 Approximately 33 million patients worldwide are living with AFib.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

FEBRUARY 27, 2024

The first procedures, performed by leading physicians Saibal Kar , MD, FACC, FSCAI, (Program Director, Cardiovascular Disease Fellowship, Los Robles Health System , California, HCA Healthcare National Physician Director, Interventional Cardiology) and Devi Nair , MD, FACC, FHRS, (Director, Cardiac Electrophysiology Division, St.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

DAIC

JANUARY 18, 2024

milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heart rhythms such as atrial fibrillation (AFib). chief medical officer of Abbott's electrophysiology business.

Heart Rhythm 105

Heart Rhythm Ablation AFIB Chest Pain 105

DAIC

APRIL 5, 2024

With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD). It is currently undergoing clinical studies in the U.S.

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105

DAIC

MAY 18, 2024

Image courtesy: Getty Images christine.book Sat, 05/18/2024 - 14:26 May 18, 2024 — The Heart Rhythm Society ( HRS ) has announced the findings of three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation ( AFib ).

Atrial Fibrillation 105

Atrial Fibrillation Heart Rhythm Ablation Quality of Life 105